Patents Assigned to Abbott Diabetes Inc.
  • Patent number: 10631768
    Abstract: Generally, embodiments of the invention relate to self-powered analyte determining devices (e.g., electrochemical analyte monitoring systems) that include a working electrode, a counter electrode, and an optional resistance value, where the working electrode includes analyte sensing components and the self-powered analyte determining device spontaneously passes a current directly proportional to analyte concentration in the absence of an external power source. Also provided are systems and methods of using the, for example electrochemical, analyte sensors in analyte monitoring.
    Type: Grant
    Filed: June 22, 2018
    Date of Patent: April 28, 2020
    Assignee: Abbott Diabetes Inc.
    Inventors: Benjamin J. Feldman, Zenghe Liu, Tianmei Ouyang